These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1527 related items for PubMed ID: 28288043

  • 1. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH, Cho A, Yun M, Choi YD, Rha SY, Kang WJ.
    Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
    [Abstract] [Full Text] [Related]

  • 2. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Renal Cell Carcinoma.
    Nakajima R, Matsuo Y, Kondo T, Abe K, Sakai S.
    Clin Nucl Med; 2017 Apr; 42(4):e177-e182. PubMed ID: 28134692
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
    Ryu IS, Kim JS, Roh JL, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
    [Abstract] [Full Text] [Related]

  • 4. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma.
    Hwang SH, Lee JW, Cho HJ, Kim KS, Choi GH, Yun M.
    Clin Nucl Med; 2017 Jan; 42(1):34-39. PubMed ID: 27775949
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW, Kang CM, Choi HJ, Lee WJ, Song SY, Lee JH, Lee JD.
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [Abstract] [Full Text] [Related]

  • 6. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY, Guo Z, Sun J, Yang WP, Li TR.
    Zhonghua Zhong Liu Za Zhi; 2018 Jul 23; 40(7):528-533. PubMed ID: 30060362
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH, Kang SM, Jeong SY, Lee SW, Lee SJ, Lee J, Ahn BC.
    Clin Nucl Med; 2016 Jun 23; 41(6):e266-73. PubMed ID: 27055144
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Rudžianskas V, Korobeinikova E, Rudžianskienė M, Jaselskė E, Adlienė D, Šedienė S, Kulakienė I, Padervinskis E, Jurkienė N, Juozaitytė E.
    Medicina (Kaunas); 2018 Dec 10; 54(6):. PubMed ID: 30544718
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL, Liang JH, Wang L, Xu W, Ding CY.
    Zhonghua Zhong Liu Za Zhi; 2019 Nov 23; 41(11):831-836. PubMed ID: 31770850
    [Abstract] [Full Text] [Related]

  • 13. Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma.
    Minamimoto R, Barkhodari A, Harshman L, Srinivas S, Quon A.
    PLoS One; 2016 Nov 23; 11(4):e0153321. PubMed ID: 27123976
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
    Im HJ, Oo S, Jung W, Jang JY, Kim SW, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS.
    Medicine (Baltimore); 2016 May 23; 95(19):e3686. PubMed ID: 27175707
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of 18 F-FDG PET/CT parameters in patients who undergo salvage treatments for recurrent squamous cell carcinoma of the larynx and hypopharynx.
    Lee JR, Almuhaimid TM, Roh JL, Oh JS, Kim SJ, Kim JS, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2018 Sep 23; 118(4):644-650. PubMed ID: 30132891
    [Abstract] [Full Text] [Related]

  • 17. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
    Hofheinz F, Li Y, Steffen IG, Lin Q, Lili C, Hua W, van den Hoff J, Zschaeck S.
    Eur J Nucl Med Mol Imaging; 2019 Jul 23; 46(7):1485-1494. PubMed ID: 30949816
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).
    Mirili C, Guney IB, Paydas S, Seydaoglu G, Kapukaya TK, Ogul A, Gokcay S, Buyuksimsek M, Yetisir AE, Karaalioglu B, Tohumcuoglu M.
    Int J Clin Oncol; 2019 Feb 23; 24(2):168-178. PubMed ID: 30109543
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 23; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 20. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
    Satoh K, Patel D, Dieckmann W, Nilubol N, Kebebew E.
    Ann Surg Oncol; 2015 Dec 23; 22 Suppl 3():S714-20. PubMed ID: 26282908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.